rs142851023
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_ModerateBP6BS1
The NM_004369.4(COL6A3):c.8009C>T(p.Ala2670Val) variant causes a missense change. The variant allele was found at a frequency of 0.000658 in 1,613,318 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A2670A) has been classified as Benign.
Frequency
Consequence
NM_004369.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A3 | NM_004369.4 | c.8009C>T | p.Ala2670Val | missense_variant | Exon 38 of 44 | ENST00000295550.9 | NP_004360.2 | |
COL6A3 | NM_057167.4 | c.7391C>T | p.Ala2464Val | missense_variant | Exon 37 of 43 | NP_476508.2 | ||
COL6A3 | NM_057166.5 | c.6188C>T | p.Ala2063Val | missense_variant | Exon 35 of 41 | NP_476507.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000605 AC: 92AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000622 AC: 156AN: 250794Hom.: 0 AF XY: 0.000657 AC XY: 89AN XY: 135512
GnomAD4 exome AF: 0.000663 AC: 968AN: 1461016Hom.: 1 Cov.: 33 AF XY: 0.000652 AC XY: 474AN XY: 726666
GnomAD4 genome AF: 0.000611 AC: 93AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000886 AC XY: 66AN XY: 74458
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
- -
COL6A3: BP4 -
- -
Bethlem myopathy 1A Benign:2
- -
- -
Ullrich congenital muscular dystrophy 1A;C4225336:Dystonia 27;CN029274:Bethlem myopathy 1A Uncertain:1
- -
not specified Uncertain:1
Variant summary: COL6A3 c.8009C>T (p.Ala2670Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00062 in 250794 control chromosomes (gnomAD). c.8009C>T has been reported in the literature in individuals affected with neuromuscular disorders without strong evidence of causality (e.g. Ankala_2015, Nallamilli_2018, Meinlke_2020, Marinella_2022). These reports do not provide unequivocal conclusions about association of the variant with Ullrich Congenital Muscular Dystrophy 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 25380242, 30564623, 31862442, 36498898). ClinVar contains an entry for this variant (Variation ID: 128822). Based on the evidence outlined above, the variant was classified as uncertain significance. -
COL6A3-related disorder Uncertain:1
The COL6A3 c.8009C>T variant is predicted to result in the amino acid substitution p.Ala2670Val. This variant has been reported in multiple patients with muscular disorders; however the pathogenicity of this change has not been elucidated with functional or segregation studies (Ankala et al. 2015. PubMed ID: 25380242; Nallamilli et al. 2018. PubMed ID: 30564623; Meinke et al. 2019. PubMed ID: 31862442; Kars et al. 2021. PubMed ID: 34426522). This variant is reported in 0.12% of alleles in individuals of Latino descent in gnomAD and 174 total heterozygotes. This is a higher frequency than other known pathogenic variants in the COL6A3 gene. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at